We are live on ! Find out more
WP

Waycross Partners Portfolio holdings

AUM $1.05B
1-Year Est. Return 20.92%
This Fund
S&P 500
This Quarter Est. Return
+12.79%
1 Year Est. Return
+20.92%
3 Year Est. Return
+78.91%
5 Year Est. Return
+114.23%
10 Year Est. Return
AUM
$276M
AUM Growth
+$127M
Cap. Flow
+$109M
Cap. Flow %
39.49%
Top 10 Hldgs %
37.86%
Holding
91
New
5
Increased
40
Reduced
12
Closed
8

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$7.18M
2
EW icon
Edwards Lifesciences
EW
+$6.15M
3
MSFT icon
Microsoft
MSFT
+$5.42M
4
ABBV icon
AbbVie
ABBV
+$5.31M
5
ULTA icon
Ulta Beauty
ULTA
+$4.97M

Top Sells

Rank Stock Value
1
CAT icon
Caterpillar
CAT
+$2.32M
2
PXD
Pioneer Natural Resource Co.
PXD
+$1.99M
3
FDX icon
FedEx
FDX
+$1.09M
4
FANG icon
Diamondback Energy
FANG
+$964K
5
DE icon
Deere & Co
DE
+$813K

Sector Composition

Rank Sector Weight
1 Technology 22.9%
2 Healthcare 21.07%
3 Financials 18.91%
4 Consumer Discretionary 17.05%
5 Industrials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
51
Bank of America
BAC
$439B
$994K 0.36%
30,000
INTU icon
52
Intuit
INTU
$85.6B
$973K 0.35%
2,500
-600
-19% -$238K
DHR icon
53
Danaher
DHR
$140B
$960K 0.35%
4,081
+20
+0.5% +$4.64K
TEAM icon
54
Atlassian
TEAM
$25.4B
$830K 0.3%
6,450
+4,250
+193% +$677K
PZZA icon
55
Papa John's
PZZA
$1.02B
$823K 0.3%
10,000
PEP icon
56
PepsiCo
PEP
$195B
$801K 0.29%
4,433
HAL icon
57
Halliburton
HAL
$26.1B
$748K 0.27%
19,000
-19,700
-51% -$697K
BMRN icon
58
BioMarin Pharmaceuticals
BMRN
$12B
$724K 0.26%
7,000
+600
+9% +$56.3K
LMT icon
59
Lockheed Martin
LMT
$134B
$705K 0.26%
1,450
DIS icon
60
Walt Disney
DIS
$172B
$695K 0.25%
8,000
ABT icon
61
Abbott
ABT
$187B
$690K 0.25%
6,289
MCD icon
62
McDonald's
MCD
$194B
$689K 0.25%
2,613
+35
+1% +$9.23K
AMGN icon
63
Amgen
AMGN
$212B
$683K 0.25%
2,600
PG icon
64
Procter & Gamble
PG
$347B
$664K 0.24%
4,382
+73
+2% +$10.2K
RCL icon
65
Royal Caribbean
RCL
$86.5B
$650K 0.24%
13,142
-3,591
-21% -$188K
CAT icon
66
Caterpillar
CAT
$387B
$647K 0.23%
2,700
-10,643
-80% -$2.32M
MRK icon
67
Merck
MRK
$326B
$622K 0.23%
5,603
+103
+2% +$10.5K
MELI icon
68
Mercado Libre
MELI
$94.4B
$564K 0.2%
667
+100
+18% +$89K
NKE icon
69
Nike
NKE
$63.9B
$550K 0.2%
4,700
MGM icon
70
MGM Resorts International
MGM
$11.8B
$535K 0.19%
15,949
PFE icon
71
Pfizer
PFE
$144B
$525K 0.19%
10,245
STX icon
72
Seagate
STX
$169B
$516K 0.19%
9,800
SNOW icon
73
Snowflake
SNOW
$93.7B
$502K 0.18%
3,500
CL icon
74
Colgate-Palmolive
CL
$74.2B
$473K 0.17%
6,000
HUM icon
75
Humana
HUM
$46.7B
$461K 0.17%
900

Similar funds

Waycross Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Waycross Partners held 91 positions worth $276M, up 85% from $149M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Waycross Partners deployed $109M of net new capital in Q4 2022, opening 5 new positions and adding to 40 existing holdings. Its largest new stake was Edwards Lifesciences: 79,756 shares worth $5.95M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Caterpillar, an estimated $2.32M trimmed.

  • Waycross Partners's largest Q4 2022 buy was Edwards Lifesciences: 79,756 shares worth $5.95M.
  • Waycross Partners added most to Apple in Q4 2022, an estimated $7.18M increase.
  • Waycross Partners's biggest Q4 2022 reduction was Caterpillar, cutting an estimated $2.32M.
  • Waycross Partners fully exited Pioneer Natural Resource Co. in Q4 2022, selling an estimated $1.99M.
  • Waycross Partners's ten largest holdings make up 38% of its $276M portfolio in Q4 2022.
  • Waycross Partners opened 5 new positions and closed 8 in Q4 2022.
  • Waycross Partners's portfolio value rose 85% quarter-over-quarter to $276M.

Based on Waycross Partners's 13F filing for Q4 2022, filed 6 Feb 2023.